Infectious diseases remain a major cause of mortality across the globe, so if pathogens could therefore be harnessed as a weapon, the implications would certainly be severe and far-reaching. Find out more about biothreats and bioterrorism in our explainer.
Browsing: Disease Area > Fungal
To round up 2017, we asked our Expert panel to choose their top papers from the year. Here, you can discover these articles and the reasons why they were chosen.
Want to find out what’s been happening this year? Editor, Martha Powell, highlights the best of 2017’s infectious diseases research in an A–Z.
This study looks at Candida tropicalis, evaluating if radiation used in radiotherapy can cause changes in the virulence potential.
A new study has identified cyclin-dependent kinases as the key regulator of chromatin snares that are essential for neutrophil immune defense.
Take a look at the Storify of our Twitter chat #TalkAMR and catch up on all the great content!
New drugs with antifungal action need to be developed. Here, the authors investigate the antifungal activity of MOL3, a small molecule that was selected by virtual screening, against Candida spp.
A novel CRISPR–Cas9-based gene drive platform has been developed by researchers and may help us understand some of the genetic networks underlying virulence in fungal pathogen, Candida albicans.
This research article from Future Microbiology investigates the species distribution and antifungal susceptibility profiles of yeast isolates causing invasive infections across Beijing.
Researchers have uncovered the pharmacodynamic properties of novel antifungal, F901318, taking it one step closer to testing in clinical trials